MicroRNA-650 Was a Prognostic Factor in Human Lung Adenocarcinoma and Confers the Docetaxel Chemoresistance of Lung Adenocarcinoma Cells via Regulating Bcl-2/Bax Expression

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Huang, Jia Yuan ^a   Cui, Shi Yun ^a   Chen, Yi Tian ^a   Song, Hai Zhu ^a   Huang, Gui Chun ^a   Feng, Bing ^a   Sun, Ming ^b   De, Wei ^b   Wang, Rui ^a   Chen, Long Bang ^a  

^a NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CASPASE 3; CISPLATIN; DOCETAXEL; INHIBITOR OF GROWTH 4; MICRORNA; MICRORNA 650; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PROTEIN EXPRESSION; RNA ANALYSIS; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BCL-2-ASSOCIATED X PROTEIN; CELL LINE, TUMOR; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; TAXOIDS; TUMOR MARKERS, BIOLOGICAL;

EID: 84882602688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072615     Document Type: Article

References (34)

1. Siegel R, Naishadham D, Jemal A, (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29. doi:10.3322/caac.20138. PubMed: 22237781.
2. Houwen L, (2003) State of the art: lung cancer in China. Ann Thorac Cardiovasc Surg 9: 147-148. PubMed: 12882182.
3. Miller YE, (2005) Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 33: 216-223. doi:10.1165/rcmb.2005-0158OE. PubMed: 16107574.
4. Ke XS, Liu CM, Liu DP, Liang CC, (2003) MicroRNAs: key participants in gene regulatory networks. Curr Opin Chem Biol 7: 516-523. doi:10.1016/S1367-5931(03)00075-9. PubMed: 12941428.
5. Mallory AC, Vaucheret H, (2004) MicroRNAs: something important between the genes. Curr Opin Plant Biol 7: 120-125. doi:10.1016/j.pbi.2004.01.006. PubMed: 15003210.
6. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. doi:10.1016/S0092-8674(04)00045-5. PubMed: 14744438.
7. Dumortier O, Van Obberghen E, (2012) MicroRNAs in pancreas development. Diabetes Obes Meta. 14: 22-28. doi:10.1111/j.1463-1326.2012.01656.x.
8. Xu J, Wang Y, Tan X, Jing H, (2012) MicroRNAs in autophagy and their emerging roles in crosstalk with apoptosis. Autophagy 8: 873-882. doi:10.4161/auto.19629. PubMed: 22441107.
9. Nikitina EG, Urazova LN, Stegny VN, (2012) MicroRNAs and human cancer. Exp Oncol 34: 2-8. PubMed: 22453141.
10. Qi J, Mu D, (2012) MicroRNAs and lung cancers: from pathogenesis to clinical implications, Front Med 6: 134-155.
11. Wang Q, Wang S, Wang H, Li P, Ma Z, (2012) MicroRNAs: novel biomarkers for lung cancer diagnosis, prediction and treatment. Exp Biol Med (Maywood) 237: 227-235. doi:10.1258/ebm.2011.011192.
12. Thomson DW, Bracken CP, Goodall GJ, (2011) Experimental strategies for microRNA target identification. Nucleic Acids Res 39: 6845-6853. doi:10.1093/nar/gkr330. PubMed: 21652644.
13. Xia W, Cao G, Shao N, (2009) Progress in miRNA target prediction and identification. Sci China C 52: 1123-1130. doi:10.1007/s11427-009-0159-4.
14. Cui SY, Huang JY, Chen YT, Song HZ, Feng B, et al. (2013) Acquisition of Chemoor Radioresistance and Epithelial to Mesenchymal Transition (EMT) Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma Cells was Linked with Downregulation of Let-7c. Mol Cancer Res: pp. 2013 Apr 5. [Epub ahead of print].
15. Wang R, Huang J, Feng B, De W, Chen L, (2012) Identification of ING4 (inhibitor of growth 4) as a modulator of docetaxel sensitivity in human lung adenocarcinomam. Mol Med 18: 874-886. PubMed: 22460125.
16. Chen PS, Su JL, Hung MC, (2012) Dysregulation of microRNAs in cancer. J Biomed Sci 19: 90. doi:10.1186/1423-0127-19-90. PubMed: 23075324.
17. Nikitina EG, Urazova LN, Stegny VN, (2012) MicroRNAs and human cancer. Exp Oncol 34: 2-8. PubMed: 22453141.
18. Iorio MV, Croce CM, (2012) microRNA involvement in human cancer. Carcinogenesis 33: 1126-1133. doi:10.1093/carcin/bgs140. PubMed: 22491715.
19. Jang JS, Jeon HS, Sun Z, Aubry MC, Tang H, et al. (2012) Increased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokers. Clin Cancer Res 18: 3658-3667. doi:10.1158/1078-0432.CCR-11-2857. PubMed: 22573352.
20. Kaduthanam S, Gade S, Meister M, Brase JC, Johannes M, et al. (2013) Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 80: 223-227. PubMed: 23410826.
21. Patnaik SK, Yendamuri S, Kannisto E, Kucharczuk JC, Singhal S, et al. (2012) MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLOS ONE 7: e46045. doi:10.1371/journal.pone.0046045. PubMed: 23029380.
22. Wang R, Wang ZX, Yang JS, Pan X, De W, et al. (2011) MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene 30: 2644-2658. doi:10.1038/onc.2010.642. PubMed: 21358675.
23. Feng L, Xie Y, Zhang H, Wu Y, (2011) Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650. Biochem Biophys Res Commun 406: 534-538. doi:10.1016/j.bbrc.2011.02.081. PubMed: 21352815.
24. Mraz M, Dolezalova D, Plevova K, Stano Kozubik K, Mayerova V, et al. (2012) MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology ofchronic lymphocytic leukemia. Blood 119: 2110-2113. doi:10.1182/blood-2011-11-394874. PubMed: 22234685.
25. Zhang X, Zhu W, Zhang J, Huo S, Zhou L, et al. (2010) MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 395: 275-280. doi:10.1016/j.bbrc.2010.04.005. PubMed: 20381459.
26. Rui W, Bing F, Hai-Zhu S, Wei D, Long-Bang C, (2010) Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1). J Cell Mol Med 14: 206-214. doi:10.1111/j.1582-4934.2009.00964.x. PubMed: 19900214.
27. Feng B, Wang R, Song HZ, Chen LB, (2012) MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 118: 3365-3376. doi:10.1002/cncr.26560. PubMed: 22139708.
28. Feng B, Wang R, Chen LB, (2012) MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Cancer Lett 317: 184-191. doi:10.1016/j.canlet.2011.11.024. PubMed: 22120675.
29. Unoki M, Kumamoto K, Takenoshita S, Harris CC, (2009) Reviewing the current classification of inhibitor of growth family proteins. Cancer Sci 100: 1173-1179. PubMed: 19432890.
30. Mathema VB, Koh YS, (2012) Inhibitor of growth-4 mediates chromatin modification and has a suppressive effect on tumorigenesis and innate immunity. Tumour Biol 33: 1-7. doi:10.1007/s13277-011-0249-3. PubMed: 21971889.
31. Li M, Jin Y, Sun WJ, Yu Y, Bai J, et al. (2009) Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J Pathol 219: 87-95. doi:10.1002/path.2571. PubMed: 19479822.
32. Liu Y, Yu L, Wang Y, Zhang Y, Wang Y, et al. (2012) Expression of tumor suppressor gene ING4 in ovarian carcinoma is correlated with microvessel density. J Cancer Res Clin Oncol 138: 647-655. doi:10.1007/s00432-011-1099-5. PubMed: 22228137.
33. Li XH, Kikuchi K, Zheng Y, Noguchi A, Takahashi H, et al. (2011) Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma. Oral Oncol 47: 217-223. doi:10.1016/j.oraloncology.2011.01.004. PubMed: 21310648.
34. Wang QS, Li M, Zhang LY, Jin Y, Tong DD, et al. (2010) Down-regulation of ING4 is associated with initiation and progression of lung cancer. Histopathology 57: 271-281. doi:10.1111/j.1365-2559.2010.03623.x. PubMed: 20716169.